Topical Sulfamylon reduces engraftment of cultured skin substitutes on athymic mice

Journal of Burn Care and Rehabilitation

Volumn 20, Issue 1 I, 1999, Pages 33-36

  Boyce, Steven T ^a,b   Supp, Andrew P ^a   Swope, Viki B ^a   Warden, Glenn D ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAFENIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; DRUG TOLERABILITY; FIBROBLAST; FULL THICKNESS SKIN GRAFT; GRAFT SURVIVAL; KERATINOCYTE; MOUSE; NONHUMAN; SKIN TRANSPLANTATION; TOPICAL DRUG ADMINISTRATION; WOUND CLOSURE; WOUND DRESSING; WOUND INFECTION;

EID: 0032950974     PISSN: 02738481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004630-199901001-00006     Document Type: Article

References (16)

1. Lindberg RB, Moncrief JA, Mason AD. Control of experimental and clinical wound sepsis by topical application of sulfamylon compounds. Ann N Y Acad Sci 1968;150:950-60.
2. Monafo WW, West MA. Current treatment recommendations for topical burn therapy. Drugs 1990;40:364-73.
3. Buehler PK, Reading GP, Jacoby FG, Harrison HN. The "Sulfamylon sandwich": a laminated mafenide-saline dressing. Ann Plast Surg 1980;5:157-9.
4. Kucan JO, Smoot EC. Five percent mafenide acetate solution in the treatment of thermal injuries. J Burn Care Rehabil 1993;14:158-63.
5. Murphy RC, Kucan JO, Robson MC, Heggers JP. The effect of 5% mafenide acetate solution on bacterial control in infected rat burns. J Trauma 1983;23:878-81.
6. Shuck JM, Thorne LW, Cooper CG. Mafenide acetate solution dressings: an adjunct in burn wound care. J Trauma 1975;15:595-9.
7. Boyce ST, Warden GD, Holder IA. Cytotoxicity testing of topical antimicrobial agents to human keratinocytes and fibroblasts for cultured skin grafts. J Burn Care Rehabil 1995;16:97-103.
8. Cooper ML, Boyce ST, Hansbrough JF, Foreman TJ, Frank DH. Cytotoxicity to cultured human keratinocytes (HK) or topical antimicrobial agents. J Surg Res 1990;48:190-5.
9. Boyce ST, Warden GD, Holder IA. Non-cytotoxic combinations of topical antimicrobial agents for use with cultured skin. Antimicrob Agents Chemother 1995;39:1324-8.
10. Boyce ST, Supp AP, Harriger MD, Pickens WL, Wickett RR, Hoath SB. Surface electrical capacitance as a non-invasive index of epidermal barrier in cultured skin substitutes in athymic mice. J Invest Dermatol 1996;107:82-7.
11. Boyce ST, Swope VB, Supp AP, Warden GD. Vitamin C promotes epidermal barrier and DNA synthesis in keratinocytes of cultured skin substitutes. Mol Cell Biol 1997;8:339a.
12. Boyce ST, Harriger MD, Supp AP, Warden GD, Holder IA. Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice. Wound Rep Reg 1997;5:191-7.
13. Boyce ST, Supp AP, Harriger MD, Greenhalgh DG, Warden GD. Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J Invest Dermatol 1995;104:345-9.
14. Boyce ST, Williams ML. Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin. J Invest Dermatol 1993;101:180-4.
15. Briggaman RA. Human skin grafts-nude mouse model: techniques and application. In: Skerrow D, Skerrow CJ, editors. Methods in skin research. New York: John Wiley and Sons; 1985. p. 251-76.
16. Demarchez M, Sengel P, Prunieras M. Wound healing of human skin transplanted onto the nude mouse. Dev Biol 1986;113:90-6.